Literature DB >> 25299931

Dynamic contrast-enhanced MRI for differentiation of major salivary glands neoplasms, a 3-T MRI study.

L Aghaghazvini1, F Salahshour, N Yazdani, H Sharifian, S Kooraki, M Pakravan, M Shakiba.   

Abstract

OBJECTIVES: Pre-operative differentiation of salivary gland neoplasms is of great importance. This study was designed to evaluate the use of dynamic contrast-enhanced MRI (DCE-MRI) for differentiation between malignant, Warthin and benign non-Warthin (BNW) neoplasms of major salivary glands.
METHODS: 46 major salivary gland tumours (SGTs) underwent pre-operative DCE-MRI. Post-surgical histopathological evaluation showed 30 BNW, 6 Warthin and 10 malignant tumours. Time-signal intensity curves (TICs) were categorized as (a) Tpeak >43 s and washout ratio at 180 s (WR180) <4.6%; (b) Tpeak <43 s and WR >22%; (c) Tpeak >43 s and WR180 = 4.6-22.0%
RESULTS: Accuracy of Tpeak was 98.9% for differentiation between BNW and Warthin tumours, 83.7% between BNW and malignant and 80% between malignant and Warthin tumours. All Warthin tumours showed Tpeak ≤43 s, while one BNW had Tpeak <43 s. A Tpeak <63.5 s differentiated 8/10 (80%) malignant tumours from BNW tumours, whereas 4/30 of BNW tumours had a Tpeak <63.5 s. Two malignant tumours had Tpeak <43 s. WR180 had an accuracy of 100% for differentiation between Warthin and BNW tumours, 87.3% between BNW and malignant, and 93.3% between Warthin and malignant tumours. 29 (96.7%) BNW tumours had a washout <4.60%, while 8 (80%) malignant tumours had a washout >4.60%. All Warthin tumours had a WR180 >22%, while two malignant tumours had a WR180 >22%. 29/30 of BNW tumours demonstrated TIC curve Type A and 1 tumour demonstrated Type C. 6/10 of malignant tumours had TIC Type C, 2 had TIC Type A and 2 Type B. All Warthin tumours were categorized as Type B.
CONCLUSIONS: This study showed that DCE-MRI could be helpful in pre-operative differentiation of SGTs; especially for discrimination between Warthin and BNW tumours.

Entities:  

Keywords:  dynamic MRI; neoplasm; salivary glands

Mesh:

Substances:

Year:  2014        PMID: 25299931      PMCID: PMC4614174          DOI: 10.1259/dmfr.20140166

Source DB:  PubMed          Journal:  Dentomaxillofac Radiol        ISSN: 0250-832X            Impact factor:   2.419


  20 in total

1.  Imaging of head and neck tumors.

Authors:  M Lenz
Journal:  Eur J Radiol       Date:  2000-03       Impact factor: 3.528

2.  Minor salivary gland tumors in the oral cavity: diagnostic value of dynamic contrast-enhanced MRI.

Authors:  Hidenobu Matsuzaki; Yoshinobu Yanagi; Marina Hara; Naoki Katase; Jun-ichi Asaumi; Miki Hisatomi; Teruhisa Unetsubo; Hironobu Konouchi; Toshihiko Takenobu; Hitoshi Nagatsuka
Journal:  Eur J Radiol       Date:  2011-12-03       Impact factor: 3.528

3.  Parotid gland lesions: diagnosis of malignancy with MRI and flow cytometric DNA analysis and cytology in fine-needle aspiration biopsy.

Authors:  S Takashima; F Takayama; Q Wang; M Kurozumi; Y Sekiyama; S Sone
Journal:  Head Neck       Date:  1999-01       Impact factor: 3.147

4.  MR imaging of parotid tumors: typical lesion characteristics in MR imaging improve discrimination between benign and malignant disease.

Authors:  A Christe; C Waldherr; R Hallett; P Zbaeren; H Thoeny
Journal:  AJNR Am J Neuroradiol       Date:  2011-06-30       Impact factor: 3.825

5.  Treatment of malignant neoplasms of the parotid gland.

Authors:  M Magnano; C F gervasio; L Cravero; G Machetta; W Lerda; G Beltramo; R Orecchia; R Ragona; M Bussi
Journal:  Otolaryngol Head Neck Surg       Date:  1999-11       Impact factor: 3.497

Review 6.  Contemporary management of tumors of the salivary glands.

Authors:  Joseph M Scianna; Guy J Petruzzelli
Journal:  Curr Oncol Rep       Date:  2007-03       Impact factor: 5.075

7.  Malignant parotid tumors: clinical use of MR imaging and histologic correlation.

Authors:  N J Freling; W M Molenaar; A Vermey; E L Mooyaart; A K Panders; A A Annyas; C J Thijn
Journal:  Radiology       Date:  1992-12       Impact factor: 11.105

8.  Parotid gland tumors: can addition of diffusion-weighted MR imaging to dynamic contrast-enhanced MR imaging improve diagnostic accuracy in characterization?

Authors:  Hidetake Yabuuchi; Yoshio Matsuo; Takeshi Kamitani; Taro Setoguchi; Takashi Okafuji; Hiroyasu Soeda; Shuji Sakai; Masamitsu Hatakenaka; Torahiko Nakashima; Yoshinao Oda; Hiroshi Honda
Journal:  Radiology       Date:  2008-10-21       Impact factor: 11.105

9.  Role of fine needle aspiration cytology in the diagnosis and management of Warthin's tumour of the salivary glands.

Authors:  J M Viguer; B Vicandi; J A Jiménez-Heffernan; P López-Ferrer; P González-Peramato; C Castillo
Journal:  Cytopathology       Date:  2009-09-09       Impact factor: 2.073

10.  Correct diagnosis of Warthin tumor in the parotid gland with dynamic MRI.

Authors:  Takenori Ogawa; Takahiro Suzuki; Maya Sakamoto; Mika Watanabe; Yutaka Tateda; Takeshi Oshima; Kengo Kato; Shun Sagai; Toshimitsu Kobayashi; Kiyoto Shiga
Journal:  Tohoku J Exp Med       Date:  2012-05       Impact factor: 1.848

View more
  7 in total

1.  The diagnostic value of combining conventional, diffusion-weighted imaging and dynamic contrast-enhanced MRI for salivary gland tumors.

Authors:  Ning Zheng; Rui Li; Wenjuan Liu; Shuo Shao; Shan Jiang
Journal:  Br J Radiol       Date:  2018-06-27       Impact factor: 3.039

Review 2.  Clinical utility of dynamic-enhanced MRI in salivary gland tumors: retrospective study and literature review.

Authors:  Takenori Ogawa; Ikuho Kojima; Ryo Ishii; Maya Sakamoto; Takaki Murata; Takahiro Suzuki; Kengo Kato; Ayako Nakanome; Akira Ohkoshi; Eiichi Ishida; Seiji Kakehata; Kiyoto Shiga; Yukio Katori
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-04-06       Impact factor: 2.503

3.  Diffusion-weighted MRI for differentiation between sialadenitis and pleomorphic adenoma.

Authors:  Guilherme T C Terra; Jefferson X D Oliveira; Adalsa Hernandez; Silvia V Lourenço; Emiko S Arita; Arthur R G Cortes
Journal:  Dentomaxillofac Radiol       Date:  2016-11-15       Impact factor: 2.419

4.  MR imaging features of mammary analogue secretory carcinoma and acinic cell carcinoma of the salivary gland: a preliminary report.

Authors:  Nobuo Kashiwagi; Shin Ichi Nakatsuka; Takamichi Murakami; Eisuke Enoki; Kazuhiro Yamamoto; Katsuyuki Nakanishi; Takaaki Chikugo; Yoshitaka Kurisu; Masatomo Kimura; Tomoko Hyodo; Akio Tsukabe; Takahide Kakigi; Yasuhiko Tomita; Kazunari Ishii; Yoshifumi Narumi; Yukinobu Yagyu; Noriyuki Tomiyama
Journal:  Dentomaxillofac Radiol       Date:  2018-03-08       Impact factor: 2.419

5.  The radiologic (CT/MRI)-pathological correlations of the salivary duct carcinoma (SDC) with hyaline degeneration and peripheral nerve invasion.

Authors:  Nobukata Kazawa; Yuta Shibamoto; Yasujirou Hirose; Yoriko Yamashita
Journal:  Dentomaxillofac Radiol       Date:  2021-04-20       Impact factor: 3.525

Review 6.  Meta-analysis of magnetic resonance imaging accuracy for diagnosis of oral cancer.

Authors:  Marcelo Aldrighi Moreira; Luiza Silveira Lessa; Francieli Regina Bortoli; Abigail Lopes; Eduardo Picolo Xavier; Renan Antonio Ceretta; Fernanda Guglielmi Faustini Sônego; Cristiane Damiani Tomasi; Patricia Duarte Simões Pires; Luciane Bisognin Ceretta; Ingrid Dalira Schweigert Perry; Priscyla Waleska Simões
Journal:  PLoS One       Date:  2017-05-24       Impact factor: 3.240

7.  Differentiation of Benign and Malignant Parotid Gland Tumors with MRI and Diffusion Weighted Imaging.

Authors:  Umut Percem Orhan Soylemez; Basak Atalay
Journal:  Medeni Med J       Date:  2021-06-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.